Clin2
NCT07744347Worth exploringNot yet recruiting

Long-term protection study of a combined vaccine

DiphtheriaTetanusPertussis

Part of Infections, Lungs & breathing clinical trials.

This study checks if the protection from an earlier vaccine (against whooping cough, diphtheria, and tetanus) lasts over time. Participants from a previous study will give blood samples to measure their immune response.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
160 people
Ages
6 years and older
Study type
Observational

Who can take part

  • You took part in the earlier safety study of the combined vaccine.
  • You are willing to show an ID and sign a consent form.
  • You have not had another DTP-type vaccine since that study ended.
  • You have not had whooping cough, diphtheria, or tetanus since that study ended.
  • You do not have a bleeding disorder (like hemophilia).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06184542Recruiting· Phase 1
New DTaP vaccine safety trial for children

This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.

Dazhou, Sichuan
NCT07492303Not yet recruiting· Phase 1
Vaccine for whooping cough, diphtheria, and tetanus in teens and adults

This trial tests a new combined vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and how well it works to boost immunity in teens and adults.

NCT07418372Not yet recruiting· Phase 1/Phase 2
Lower-dose vaccine for diphtheria, tetanus, and whooping cough

This study tests a lower-dose vaccine that protects against diphtheria, tetanus, and whooping cough. It aims to see if the vaccine is safe and how well it works for people aged 6 and older, possibly offering a booster with fewer side effects.

Chongqing, Chongqing Municipality
NCT07621341Not yet recruiting· Phase 4
Whooping cough vaccine in pregnancy to protect babies

This study tests a new type of whooping cough vaccine given to pregnant women to see if it helps protect their babies from whooping cough in the first months of life. The vaccine is given during pregnancy, and then the baby's immune response is checked up to 15–18 months old.

Chiang Mai
NCT07807033Not yet recruiting
Long-term immune response check after tetanus vaccine

This study checks how long your body's protection from the tetanus vaccine lasts. It follows up with people who already got the vaccine in an earlier study to see if their immunity is still strong years later.

Bijie, Guizhou
NCT07112144Recruiting· Phase 3
DTaP vaccine trial for healthy infants aged 2 months

This trial tests a new vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy infants who are about 2 months old and live permanently in the area. The goal is to see if the vaccine is safe and works well.

Wenshan Zhuang and Miao Autonomous Prefecture, Yunnan

Hear when a new Diphtheria trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.